Gene Therapy Market Statistics 2025-2033 | Regional Breakdown & US Tariff Influence - Most Leading Companies - Alnylam Pharmaceuticals, Inc., Spark Therapeutics, Inc., Novartis AG, bluebird bio, Inc

The Global Gene Therapy Market reached US$ 4.79 billion in 2024 and is expected to reach US$ 35.91 by 2033, growing at a CAGR of 23.1% during the forecast period 2025-2033.

Gene Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/gene-therapy-market?kb

Gene therapy is a cutting-edge medical technique that involves modifying or replacing defective genes within an individual's cells to treat or prevent diseases. This innovative approach can correct genetic disorders at their source by inserting healthy genes, inactivating malfunctioning ones, or introducing new genes to help fight disease. It holds promise for treating a wide range of conditions, including inherited disorders, certain cancers, and viral infections.

List of the Key Players in the Gene Therapy Market:

Alnylam Pharmaceuticals, Inc., Spark Therapeutics, Inc., Novartis AG, bluebird bio, Inc., Ferring Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Sarepta Therapeutics, Inc., CSL Behring LLC, Amgen, Inc., Orchard Therapeutics group, Krystal Biotech, Inc. among others.

Industry Development:

In March 2024, Orchard Therapeutics, now part of Kyowa Kirin, unveiled its U.S. launch plans for Lenmeldy (atidarsagene autotemcel) - the first FDA-approved gene therapy for treating children with early-onset metachromatic leukodystrophy (MLD). MLD is a rare and aggressive neurometabolic disorder, impacting approximately one in 100,000 live births, and is known for its rapid progression and fatal outcomes.

In September 2024, Vertex Pharmaceuticals Incorporated announced that Health Canada had approved CASGEVY (exagamglogene autotemcel) for marketing. The therapy is authorized for individuals aged 12 and older with sickle cell disease (SCD) experiencing recurrent vaso-occlusive crises (VOCs) or those with transfusion-dependent beta-thalassemia (TDT). CASGEVY is an autologous, genome-edited, hematopoietic stem cell-based therapy. Approximately 2,000 patients in Canada are estimated to be eligible for this treatment, with the majority affected by SCD.

In October 2024, Roche partnered with Dyno Therapeutics to utilize Dyno's engineered adeno-associated virus (AAV) capsid platform for the development of next-generation AAV vectors aimed at treating unspecified neurological diseases. The collaboration has the potential to generate over $1 billion for Dyno.

Assessing the Effects of U.S. Tariffs on the Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Gene Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/gene-therapy-market?kb

Segment Covered in the Gene Therapy Market:

By Approach, Ex-Vivo, In-Vivo

By Vector Type: Viral Vectors, Adeno-Associated Virus, Herpes Simplex Virus, Lentivirus, Non-Viral Vectors

By Technique: Gene Addition, Gene Silencing, Gene Editing

By Application: Oncology, Musculoskeletal Conditions, Blood Disorders, Rare Diseases, Ophthalmology, Others

Regional Analysis for Gene Therapy Market:

The regional analysis of the Gene Therapy Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/gene-therapy-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Gene Therapy market?

➠ Who are the leading manufacturers in the global Gene Therapy industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Gene Therapy industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Gene Therapy market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.